TPC

Takeda Pharmaceutical Company Portfolio holdings

AUM $16.4M
1-Year Est. Return 195.93%
This Quarter Est. Return
1 Year Est. Return
+195.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4M
AUM Growth
-$3.18M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11
New
Increased
Reduced
Closed

Top Buys

1 +$223K

Top Sells

1 +$13.4M
2 +$322K
3 +$200K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVID icon
1
Ovid Therapeutics
OVID
$100M
$9.79M 59.82%
7,531,996
EQ icon
2
Equillium
EQ
$67M
$2.61M 15.94%
1,824,977
XLO icon
3
Xilio Therapeutics
XLO
$34.9M
$1.24M 7.59%
1,475,121
STTK icon
4
Shattuck Labs
STTK
$192M
$1.23M 7.53%
515,619
LYEL icon
5
Lyell Immunopharma
LYEL
$698M
$891K 5.45%
54,887
+13,722
AMWL icon
6
American Well
AMWL
$77.6M
$478K 2.92%
77,733
RANI icon
7
Rani Therapeutics
RANI
$143M
$102K 0.62%
203,190
LAB icon
8
Standard BioTools
LAB
$608M
$21.5K 0.13%
16,515
HLVX
9
DELISTED
HilleVax
HLVX
-6,724,000
THRD
10
DELISTED
Third Harmonic Bio
THRD
-36,835
TSBX
11
DELISTED
Turnstone Biologics
TSBX
-895,824